Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
Omid Hamid, MD, gives his perspective on the use of tumor-infiltrating lymphocyte therapy for patients with melanoma.
Is IL-2 Still Indicated for Melanoma and RCC? What a Question to Ask!
There has never been a referendum on IL-2. True, in the era of paradigm-shifting therapies, IL-2 may be overlooked at times, but it must not be excluded from the conversation.